Clinical trials
Risk Factors clinical trials
Below are recruiting risk factors clinical trials, each written for real people, not researchers. We’re tracking 353 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07661589Recruiting
Blood transfusion risks and cell saver in children's scoliosis surgery
This trial looks at how often blood transfusions are needed during scoliosis surgery in children and whether using a device that recycles lost blood (cell saver) can reduce that need.
TunisAges Up to 17 years - NCT07572721Enrolling by invitation
Virtual Fitness and Health Program for Heart Health
This study tests a virtual fitness program delivered through Peloton and wearable fitness trackers to help adults improve their heart health and fitness. You'll exercise from home, track your progress with a device you already own, and provide blood samples to measure your health improvements.
San Francisco, CaliforniaAges 30–60 - NCT07435207Enrolling by invitation
Blood clot risk study in CRPS patients
This study looks at factors that might increase the risk of blood clots in people with CRPS (Complex Regional Pain Syndrome). It aims to help doctors better understand and manage these risks.
Pavia, PaviaAges 18 years+ - NCT07128771Enrolling by invitation
Heart effects of gender-affirming hormone therapy
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels. It aims to understand any changes in heart health for transgender individuals starting or continuing this treatment.
Oslo, OsloAges 16 years+ - NCT07070284Enrolling by invitation
Severe pneumonia in older adults: a study of risks and outcomes
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
Zagreb, City of ZagrebAges 65 years+ - NCT06957548Enrolling by invitation
Heart and diabetes risk in Cameroon adults
This study looks at risk factors for heart disease and diabetes in adults living in or from Cameroon. It involves a simple screening to better understand your health.
Douala, Littoral RegionAges 18 years+ - NCT06892899Enrolling by invitation
Exercise study for knee health after ACL surgery
This study tests whether a specific exercise program can improve knee health in people who have had ACL surgery. It aims to understand how exercise affects the knee after injury and may help prevent arthritis.
Oslo, OsloAges 16–40 - NCT06823115Enrolling by invitation
Worldwide study of kidney injury in newborns
This study looks at how common acute kidney injury is in newborns in the intensive care unit. It helps doctors understand which babies are at risk and how to prevent kidney problems.
Birmingham, AlabamaAges birth–2 weeks - NCT06812767Enrolling by invitation
Chronic disease risks in working-age people
This study looks at risk factors for chronic diseases in healthy working-age adults. You may help researchers understand how to prevent conditions like heart disease or diabetes.
MoscowAges 18 years+ - NCT06810232Enrolling by invitation
Health factors and longer hospital stay after endoscopy
This study looks at how general health factors (like age and other medical conditions) might affect how long you need to stay in the hospital after a routine stomach or bowel exam called an endoscopy. The goal is to understand which patients may need extra care so hospitals can plan better.
IstanbulAges 18 years+ - NCT06591442Enrolling by invitation
Spinal Fusion Recovery in Older Adults
This study is looking at how older adults recover after spinal fusion surgery, a type of back surgery that connects bones in the spine. The goal is to find factors that help people heal faster and feel better afterward.
Wuhan, HubeiAges 60 years+ - NCT06545305Enrolling by invitation
Eye problems in homocystinuria patients, 2018–2022
This study looks at eye problems in people with homocystinuria. It will review medical records from 2018 to 2022 to find out how common eye issues are and what might increase the risk.
JeddahAges 20–30 - NCT04840030Enrolling by invitation
Preventing Memory and Thinking Decline With Multidomain Program
This study tests a multi-part program (not just one activity) to help slow down memory and thinking decline in older adults at higher risk. You would complete brief thinking tests and follow the study’s coaching/intervention schedule to see if it helps over time.
Donostia / San Sebastian, GipuzkoaAges 60–85 - NCT03089827Enrolling by invitation
Tests how a brain imaging tracer spreads in Alzheimer’s risk
This trial uses a radioactive imaging tracer to see how it moves and settles in the brain in people with risk factors for Alzheimer’s disease. It may help researchers understand which people show tracer patterns linked to Alzheimer’s changes.
Winston-Salem, North CarolinaAges 55 years+ - NCT01193647Enrolling by invitation
Study genetics that may raise rotator cuff injury risk
This study looks at genetic (inherited) factors that may make some people more likely to develop rotator cuff tears. You may be able to join if you’ve had a shoulder MRI for pain or you’re a close family member of someone with a documented tear.
Salt Lake City, UtahAges 18 years+ - NCT05768464RecruitingPhase 2
Surgery aftercare for non-clear kidney cancer at high risk
This Phase 2 trial studies an after-surgery treatment for people with non-clear types of kidney cancer who are at high risk of coming back. It aims to lower the chance of recurrence by giving extra therapy after your tumor is completely removed.
Nanjing, JiangsuAges 18–75 - NCT05920863RecruitingPhase 2
Lenvatinib, immunotherapy, plus liver artery treatment before surgery
This Phase 2 trial tests whether giving lenvatinib and immunotherapy along with TACE (a liver artery treatment) before surgery can lower the risk of hepatocellular carcinoma coming back after surgery. It targets people with certain higher-risk early-stage liver tumors (CNLC IB/IIA).
Hangzhou, ZhejiangAges 18–75 - NCT06137196Recruiting
Lung function risks after severe pneumonia in AIDS patients
This study looks at why some people with AIDS who recover from severe pneumonia later have trouble breathing. Researchers want to find risk factors so they can help prevent lung damage.
Guangzhou, GuangdongAges 18–65 - NCT06208462RecruitingPhase 2
Combination therapy before surgery for high-risk bile duct cancer
This trial tests a combination of chemotherapy directly into the liver artery, an immunotherapy drug, and a targeted therapy pill before surgery for a type of bile duct cancer that has a high chance of coming back. The goal is to see if this approach can improve outcomes for patients whose cancer is still removable but has certain high-risk features.
Nanjing, JiangsuAges 18–75 - NCT06112418Recruiting
Personalized vs standard care to prevent heart attacks
This trial compares two ways to prevent heart attacks and strokes: one uses a special heart CT scan to guide care, the other uses standard risk factors like blood pressure and cholesterol. You may be eligible if you are older (men over 55, women over 65) and have diabetes, prediabetes, or metabolic syndrome.
Chandler, ArizonaAges 55 years+ - NCT06365281Recruiting
Cavity risk study for adults 35–44 years old
This study looks at how common cavities are and what factors might increase the risk of them in people ages 35–44. By joining, you'll help researchers learn more about oral health in this age group among Egyptians.
GizaAges 35–44 - NCT06365671RecruitingPhase 2
CAR-T therapy after stem cell transplant for high-risk B-cell lymphoma
This trial tests a combination treatment: a stem cell transplant followed by CAR-T cell therapy for people with B-cell lymphoma that has come back or not responded to treatment. It is for those with high-risk features like large tumors or certain genetic changes.
ShanghaiAges 18 years+ - NCT07337421RecruitingPhase 2
Chemo infusion after liver cancer surgery to lower recurrence risk
This trial tests whether a targeted chemotherapy infusion directly into the liver's main artery (HAIC) after surgery can prevent liver cancer from coming back. It is for people with certain high-risk features, like a large tumor or cancer in blood vessels, who have had their tumor completely removed.
Yangzhou, JiangsuAges 18–75 - NCT07337460RecruitingPhase 2
Icaritin plus chemotherapy for high-risk liver cancer after surgery
This trial tests combining a natural compound (Icaritin) with standard chemotherapy (mFOLFOX) after liver cancer surgery to lower the chance of the cancer coming back. It is for patients whose cancer had certain high-risk features, like a large tumor or cancer in blood vessels.
Yangzhou, JiangsuAges 18–75
Hear when a new Risk Factors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for risk factors?
- Yes. Clin2 currently lists 353 recruiting risk factors studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a risk factors trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a risk factors trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.